维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Alessio DA"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	2018年美国糖尿病学会和欧洲糖尿病研究协会关于2型糖尿病高血糖管理的共识显示文摘美国糖尿病学会(ADA)和欧洲糖尿病研究协会(EASD)近期组织专家对2012—2015年间发表的关于成年2型糖尿病的管理共识进行了更新。专家组系统评价了2014年至今发表的文献,对高血糖的管理提出了新的共识。新共识包括更加强调2型糖尿病患者的生活方式管理、自我管理教育和支持。共识指出对于2型糖尿病伴肥胖者建议通过生活方式干预、药物和手术进行减重。	Davies MJ D'Alessio DA Fradkin J 姜莹莹(编译)	2019	中华预防医学杂志2019，53，2：	19
2	Effects of glucagon like peptide-1 to mediate glycemic effects of weight loss surgery显示文摘	Salehi M D'Alessio DA	2014	Rev Endocr Metab Disord2014，15，3：	1
3	GLP-1 and energy balance: an integrated model of short-term and long-term control显示文摘	Barrera JG Sandoval DA D'Alessio DA	2011	Nat Rev Endocrinol2011，7，9：	1
4	Type 2 diabetes,thiazolidinediones:bad to the bone显示文摘	Watts NB Alessio DA	2006	J Clin Endocrinol Metab2006，91，9：	1
5	Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose 显示文摘	Greenbaum CJ Prigeon RL D' Alessio DA	2002	Diabetes2002，51，：	1
6	Targeting beta-cell mass in type 2 diabetes:promise and limitations of new drugs based on incretins显示文摘	Salehi M Aulinger BA D'Alessio DA	2008	Endocr Rev2008，29，：	1
7	GLP-1 and energy balance:an integrated model of short-term and long-term control显示文摘	Barrera JG Sandoval DA D'Alessio DA	2011	Nat Rev Endocrinol2011，7，9：	1
8	Targeting beta-cell mass in type 2 diabetes:promise and limitations of new drugs based on incretins显示文摘	Salehi M Aulinger BA D'Alessio DA	2008	Endocr Rev2008，29，3：	1
9	Glucagon- like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose dis- posal显示文摘	D'ALESSIO DA KAHN SE LEUSNER CR	1994	Clin lnvet1994，93，5：	1
10	Distribution of glucagonlike peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei显示文摘	Tauchi M Zhang R D'Alessio DA	2008	J Chem Neuroanat2008，36，34：	1
11	New ways in which GLP- 1 can regulate glucose homeostasis 显示文摘	D'Alessio DA Sandoval DA Seeley ILl	2005	J Clin Invest2005，115，12：	1
12	Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes显示文摘	D'Alessio DA Denney AM Hermiller LM	2009	J Clin Endocrinol Metab2009，94，：	1
13	Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins 显示文摘	Lehi M Aulinger BA D'Alessio DA	2008	Endocr Rev2008，29，3：	1
14	Targeting \|3 -cell massin type 2 diabetes : promise and limitations of uew drugsbased on incretins显示文摘	Salehi M Aulinger BA D'Alessio DA	2008	Endocr Rev2008，29，3：	1
15	GLP-1 and energy balance: an integrated model of short-term and long-term control 显示文摘	Barrera JG Sandoval DA D' Alessio DA	2011	Nature Reviews2011，7，9：	1
16	Targeting beta - cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins 显示文摘	Salehi M Aulinger BA D' Alessio DA	2008	Endocr Rev2008，29，3：	1
17	Targeting β-cell mass in type diabetes:promise and limitations of new drugs based on incretins显示文摘	Salehi M Aulinger BA D'Alessio DA		0，，03：	1
18	Targetingβ-cell mass in type 2 diabetes:promise and limitations of new drugs based on incretins显示文摘	Salehi M Aulinger BA D’Alessio DA	2008	Endocr Rev2008，29，2：	1
19	The role of central glucagon-like peptide-1 in mediating the effects of visceral illness:differential effects in rats and mice显示文摘	Lachey JL D'Alessio DA Rinaman L	2005	Endocrinology2005，146，1：	1
20	A sweet spot for the bariatric surgeon显示文摘	Perez-Tilve D D'Alessio DA Tschop MH		0，，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示